?> Liposomal Doxorubicin Side Effects | Lipodox Caelyx
1800 202 8726

HomeChemotherapy › Liposomal Doxorubicin — A Different Side-Effect Profile

About Liposomal Doxorubicin

Liposomal Doxorubicin A Different Side-Effect Profile

Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026

Lipodox and Caelyx are both names for the same medicine — a version of doxorubicin enclosed in a tiny fat shell that changes how it distributes in your body. The main result: lower risk of heart damage, higher chance of skin problems on the palms and soles.

Prescription-only medicine.

Liposomal doxorubicin is a prescription-only medicine given by intravenous infusion in a hospital or day-care oncology unit under the direct supervision of a specialist oncologist. Nothing in this page should be used to start, adjust, or stop treatment. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.
412Chemotherapy pages, written and reviewed
17Oncologists on the panel
10Centres across Hyderabad
41Locations across two states

In short

Liposomal doxorubicin (Lipodox, Caelyx) has a lower risk of heart damage than conventional doxorubicin, but causes more hand-foot syndrome — redness and pain in your palms and soles. Both are forms of the same drug; the liposome coating changes where it accumulates in your body, which reshapes the side-effect profile.

In detail

How is liposomal doxorubicin different from regular doxorubicin?

Doxorubicin is enclosed inside a tiny fat bubble — a liposome — coated with a molecule called PEG. This coating changes how the drug moves through the body after it enters the bloodstream.

Conventional doxorubicin enters heart muscle cells and accumulates there with each dose. The liposome shell substantially slows that entry. ASCO and ESMO guidelines recognise this as reducing the risk of cumulative cardiac toxicity compared to the conventional form.

In exchange, the drug concentrates in small blood vessels in the skin — particularly in the palms and soles — which is why hand-foot syndrome is more common with this form than with conventional doxorubicin.

Lipodox and Caelyx contain the same active molecule. The difference is in how it is packaged for delivery, not in the cancer it is used against.

Step by step

What happens during a liposomal doxorubicin infusion?

Blood tests before each cycle

A blood count is taken before treatment starts. If your counts are not within the range your oncologist has set, the cycle may be delayed until they recover.

Pre-infusion medicines

You will usually be given medicines through your drip before the infusion starts — typically an antihistamine — to reduce the chance of a reaction, particularly during the first infusion.

Slow infusion

The drug runs as a slow intravenous drip. It is given slowly by design to reduce infusion-related reactions. Your nurse will monitor you throughout.

Observation after the drip ends

You will stay for a period after the infusion to allow your team to check for any delayed reaction before you go home.

Skin care instructions for home

Your team will give you instructions about moisturising your palms and soles starting that same day. Starting skin care early — before the first sign of redness — is the single most effective thing you can do to reduce hand-foot syndrome severity.

Eligibility

Who should not have this medicine?

Liposomal doxorubicin is not suitable for everyone. Eligibility in each case is decided by an oncologist based on a full clinical assessment.

  • You have already received a high cumulative lifetime dose of doxorubicin or other anthracyclinesEven the liposomal form adds to that total.
  • You have a current severe cardiac condition, particularly reduced left-ventricular ejection fraction, as the drug can still affect heart muscle.
  • Your blood counts have not recovered sufficiently after previous treatmentYour team will check before each cycle.
  • You are pregnant or breastfeedingIt can harm a developing baby.
  • You have a known hypersensitivity to doxorubicin or to the PEGylated liposome carrier.

Your oncologist will review your cardiac function, prior treatment history, and current blood counts before considering this medicine.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

One call. No cost and no obligation.

In detail

What is hand-foot syndrome, and how do you reduce it?

Hand-foot syndrome — also called palmar-plantar erythrodysesthesia or PPE — appears as redness, warmth, swelling, tenderness, or peeling in the palms and soles. In more severe cases it can progress to blistering or broken skin that makes walking or gripping painful.

It happens because liposomal doxorubicin leaks from small blood vessels in areas of pressure and friction. Apply a thick moisturiser to palms and soles twice a day, starting before your first cycle. Wear well-fitting footwear and avoid activities that heat or put friction on your hands and feet in the days after each infusion.

Tell your team at the first sign of redness or tenderness, before it progresses. Early intervention — adjusting timing, skin care, or the next dose — is far easier than managing broken skin.

Question by question

Other questions about liposomal doxorubicin

Is the cardiac risk completely removed?

No. The liposomal form carries a substantially lower risk of cumulative cardiac toxicity than conventional doxorubicin — this is documented in ASCO and ESMO guidance and is the main clinical reason it is chosen for people who have already received a significant anthracycline dose or have an existing heart concern. But the risk is not zero, and the drug still adds to your lifetime anthracycline exposure. Cardiac monitoring — usually echocardiograms at intervals your oncologist sets — continues throughout treatment.

Will I lose my hair?

Hair thinning and significant hair loss are less common with liposomal doxorubicin than with conventional doxorubicin, though some people do notice thinning. It is not guaranteed to be mild for everyone. If hair loss does happen, it is temporary and typically recovers after treatment ends. Ask your team what to expect for your specific situation, as individual experience varies.

Will I feel as sick as with regular chemotherapy?

Nausea and vomiting are generally less severe with this form than with conventional doxorubicin, though they can still occur. Your team will give you anti-nausea medicines as part of the infusion and to take home. Many people find the nausea more manageable than they expected, though that varies from person to person. Report any nausea that prevents you from eating or drinking — it can be better controlled with the right medicines.

What are infusion reactions and how common are they?

Some people experience a reaction during or shortly after the first infusion — flushing, a feeling of tightness in the chest, back pain, or a change in blood pressure. This is typically a response to the liposome carrier rather than to doxorubicin itself, which is why the first infusion is run slowly and your nurse monitors you throughout. If a reaction happens, the infusion is paused and medicines are given. Most people tolerate subsequent cycles without recurrence.

How soon does hand-foot syndrome appear?

It typically appears after the early cycles rather than immediately. It tends to worsen with each subsequent cycle if skin care is not started early — this is why moisturising and friction-avoidance should begin before your first infusion, not after the first redness appears. If you notice any change in your palms or soles between cycles, report it at your next appointment or sooner if it is causing pain.

Can I still get mouth sores?

Mouth sores and changes in taste can occur, though they are reported less frequently with liposomal doxorubicin than with conventional doxorubicin. If you notice soreness, ulcers, or a change in how food tastes, mention it to your team. Sores that make it difficult to eat or drink should be reported sooner rather than waiting for your next scheduled visit.

Worth knowing

Did you know?

Conventional doxorubicin has a restricted maximum lifetime dose specifically because heart damage accumulates and becomes dose-limiting. Liposomal doxorubicin was developed to address that ceiling.

ASCO and ESMO guidelines recognise a meaningfully higher cumulative dose threshold for the liposomal form — the primary reason it is used when cardiac exposure from prior treatment is already a concern.

Source: ASCO / ESMO Guidelines on Anthracycline Cardiotoxicity and Cardiac Safety in Oncology

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Common questions

Frequently asked questions

What is the difference between Lipodox and Caelyx?

They contain the same medicine — PEGylated liposomal doxorubicin — and work identically. Caelyx is the original branded version and Lipodox is a generic equivalent. Your oncologist or hospital pharmacy chooses between them based on availability and institutional practice, not on any clinical difference. If your prescription names one and you are given the other, that is standard practice and not a cause for concern.

Can I manage hand-foot syndrome at home?

You can reduce its severity with thick moisturisers applied to palms and soles, well-fitting footwear, and reduced friction and heat to the hands and feet in the days after each infusion. What you cannot manage at home is a case that has progressed to blistering, broken skin, or pain that affects walking or daily tasks — those need your team to assess, because a dose adjustment may be needed. Report early rather than waiting to see if it settles on its own.

Should I be worried about my heart if I am on this medicine?

You do not need to be alarmed, but stay engaged with the monitoring your team has set up. The liposomal form has a lower cardiac risk profile than conventional doxorubicin, and that is well-established in ASCO and ESMO guidance. However, it is still an anthracycline and still requires periodic cardiac checks. If you experience new shortness of breath, an irregular heartbeat, or unusual swelling in your legs, contact your team the same day rather than waiting for a scheduled visit.

Is this medicine the same as chemotherapy?

Yes. Liposomal doxorubicin is a chemotherapy medicine — it is a cytotoxic drug that kills rapidly dividing cells. The liposome packaging changes how it is distributed in the body and modifies the side-effect profile, but does not change its fundamental mechanism of action. It is not immunotherapy, targeted therapy, or a hormone-based treatment.

Can I continue my regular medicines while on this treatment?

Ask your oncologist about every medicine you take, including over-the-counter medicines, vitamins, herbal supplements, and Ayurvedic preparations. Some medicines interact with liposomal doxorubicin or affect how it is processed in the body. Your team cannot advise on interactions they do not know about, so giving a complete and honest list at each appointment is important — even things that feel too minor to mention.

What should I tell my oncologist if my hands and feet are painful?

Tell them how the skin looks — whether there is redness, peeling, or blistering — and how long it has been present. Tell them whether it is affecting your ability to walk, grip, or carry out daily tasks. They will grade the severity and decide whether to continue, delay, or adjust the next cycle. Underreporting because you do not want to disrupt treatment is one of the things that leads to a more severe reaction. Your team needs accurate information to protect you.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu, Medical Oncologist at CION Cancer Clinics

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Dr. C. Raghavendra Reddy, Medical Oncologist at CION Cancer Clinics

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Dr. Bharati Devi Gorantla, Medical Oncologist at CION Cancer Clinics

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Dr. Owais Mohammed, Medical Oncologist at CION Cancer Clinics

Dr. Owais Mohammed

Medical Oncologist
Dr. T. Raghavender Reddy, Medical Oncologist at CION Cancer Clinics

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Dr. N. Kiranmayee, Medical Oncologist at CION Cancer Clinics

Dr. N. Kiranmayee

Medical Oncologist

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.
list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->
Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12
Call now Book free consultation